The recent interest in the potential for ketamine as an antidepressant has led to speculation about the possible mechanisms that might underlie this effect. Although they do not permit the study of intracellular mechanisms, neuroimaging methods allow the study of biologically relevant changes in brain function and neurochemistry, which may help to elucidate the processes underlying the therapeutic benefit of ketamine in patients with depression. In this presentation, I will discuss current theories about the biological underpinnings of the antidepressant effects of ketamine. I will discuss the acute and subacute effects of ketamine on brain glutamate levels, as measured using proton magnetic resonance spectroscopy. I will also discuss ketamine effects on functional connectivity, blood flow and neuroreceptor binding, and consider how these might be related to its antidepressant properties.
Venue and Contact
This is a FREE event. No need to book. Please check this page for any updates or changes before attending the event.
Become an SCI Member and save on this and future events
See Membership Options
Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations
Booking terms and conditions
SCI Members attending this meeting are able to claim CPD points.
James Stone, Kings College London